454 Existence Sciences enters co-marketing agreement with Fluidigm 454 Life Sciences.

454 Existence Sciences enters co-marketing agreement with Fluidigm 454 Life Sciences, a Roche Firm, and Fluidigm Corporation announced today they have entered a worldwide co-promotional agreement for the companies’ complementary amplicon sample planning and high-throughput sequencing systems. Fluidigm’s Access Array Program enables automated digesting of 48 exclusive samples against 48 unique amplicons, resulting in PCR products which are prepared for emPCR amplification and sequencing with 454 Life Sciences’ GS Junior or GS FLX Program. The partnership gives users a robust and streamlined workflow that minimizes the amount of manual steps required for targeted sequencing applications, including genotyping and uncommon variant detection.Obviously, concussions certainly are a component of sport, but we are able to decrease their occurrence by limiting harmful situations. Youngsters must pursue their activities in a secure environment where people understand how to treat concussions.’.

Abdominal pain duration influences appendicitis imaging diagnosis By Liam Davenport, MedWire Reporter Clinicians should not depend on ultrasonography for diagnosing pediatric appendicitis early in the course of illness, say US researchers. They discovered that the sensitivity and detrimental predictive value of ultrasonography improved with longer duration of abdominal pain, whereas computed tomography demonstrated high sensitivity irrespective of pain duration.